Subscribe To
CBIO / Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex
CBIO News
By InvestorPlace
February 28, 2023
Why Is Catalyst Biosciences (CBIO) Stock Up 55% Today?
Catalyst Biosciences (NASDAQ: CBIO ) stock is rocketing higher on Tuesday after the company announced an asset purchase agreement with GC Biopharma. T more_horizontal
By Benzinga
May 23, 2022
Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex
Catalyst Biosciences Inc (NASDAQ: CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals more_horizontal